American Conference Institute (ACI) will be holding is 12th Annual Summit on Biosimilars & Innovator Biologics: Legal, Regulatory, and Commercial Strategies for the Innovator and Biosimilars Marketplace on June 22-22, 2021 as a virtual conference. ACI faculty will offer presentations on the following topics: • Regulatory and Legislative Developments Impacting the Biopharmaceutical Industry • The Impact of Amgen v Sanofi on In-House Patenting Strategies • The “Skinny Label” Post-GSK v Teva regarding Biosimilar Carve-Outs • Litigation Strategies for Challenging Reference Drug Patents in IPRs • APJs speaking on Practice, Policy, and Procedure • A “Think Tank” on State and Federal…
